I agree that this site is using cookies. You can find further informations here.
X
Ueshima, Kazuomi
160  results:
Search for persons X
?
1

Two Distinct Characteristics of Immune Microenvironment in ..:

Aoki, Tomoko ; Nishida, Naoshi ; Kurebayashi, Yutaka...
Liver Cancer.  13 (2023)  3 - p. 285-305 , 2023
Link: https://doi.org/10.1159/..
 
?
2

Overall survival and objective response in advanced unresec..:

Kudo, Masatoshi ; Finn, Richard S. ; Qin, Shukui...
Journal of Hepatology.  78 (2023)  1 - p. 133-141 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Role of β-Catenin Activation in the Tumor Immune Microenvir..:

Morita, Masahiro ; Nishida, Naoshi ; Aoki, Tomoko...
Cancers.  15 (2023)  8 - p. 2311 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐do..:

Kamata, Ken ; Imai, Hajime ; Matsumoto, Hisakazu...
JGH Open.  7 (2023)  9 - p. 659-666 , 2023
Link: https://doi.org/10.1002/..
 
?
5

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Tr..:

Kudo, Masatoshi ; Ueshima, Kazuomi ; Saeki, Issei...
Liver Cancer.  13 (2023)  1 - p. 99-112 , 2023
Link: https://doi.org/10.1159/..
 
?
6

Clinical Practice Guidelines for Hepatocellular Carcinoma: ..:

Hasegawa, Kiyoshi ; Takemura, Nobuyuki ; Yamashita, Tatsuya...
Hepatology Research.  53 (2023)  5 - p. 383-390 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Incidence of Hyper Progressive Disease in Combination Immun..:

Aoki, Tomoko ; Kudo, Masatoshi ; Ueshima, Kazuomi...
Liver Cancer.  13 (2023)  1 - p. 56-69 , 2023
Link: https://doi.org/10.1159/..
 
?
8

Achievement of Complete Response and Drug-Free Status by At..:

Kudo, Masatoshi ; Aoki, Tomoko ; Ueshima, Kazuomi...
Liver Cancer.  12 (2023)  4 - p. 321-338 , 2023
Link: https://doi.org/10.1159/..
 
?
9

Non-Inflamed Tumor Microenvironment and Methylation/Downreg..:

Nishida, Naoshi ; Aoki, Tomoko ; Morita, Masahiro...
Cancers.  15 (2023)  8 - p. 2379 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Progression from early to advanced stage of immune‐related ..:

Hagiwara, Satoru ; Yoshida, Takeshi ; Nishida, Naoshi...
Hepatology Research.  52 (2022)  10 - p. 888-892 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Real Life Study of Lenvatinib Therapy for Hepatocellular Ca..:

Casadei-Gardini, Andrea ; Rimini, Margherita ; Kudo, Masatoshi...
Liver Cancer.  11 (2022)  6 - p. 527-539 , 2022
Link: https://doi.org/10.1159/..
 
?
12

Final Results of TACTICS: A Randomized, Prospective Trial C..:

Kudo, Masatoshi ; Ueshima, Kazuomi ; Ikeda, Masafumi...
Liver Cancer.  11 (2022)  4 - p. 354-367 , 2022
Link: https://doi.org/10.1159/..
 
?
13

Clinical implication of immune checkpoint inhibitor on the ..:

Hagiwara, Satoru ; Nishida, Naoshi ; Ida, Hiroshi...
Hepatology Research.  52 (2022)  9 - p. 754-761 , 2022
Link: https://doi.org/10.1111/..
 
?
14

Hepatectomy versus sorafenib for advanced hepatocellular ca..:

Komatsu, Shohei ; Ueshima, Kazuomi ; Kido, Masahiro...
Journal of Hepato-Biliary-Pancreatic Sciences.  30 (2022)  3 - p. 303-314 , 2022
Link: https://doi.org/10.1002/..
 
?
15

Prognostic Factors for Overall Survival in Patients with HC..:

Minami, Yasunori ; Aoki, Tomoko ; Chishina, Hirokazu...
Cancers.  14 (2022)  19 - p. 4850 , 2022
Link: https://doi.org/10.3390/..
 
1-15